(IPX) IperionX American - Ratings and Ratios
Titanium, Powders, Metals
Description: IPX IperionX American August 26, 2025
IperionX Limited (NASDAQ:IPX) is a Diversified Metals & Mining company with a market capitalization of $1.31 billion. The stock has demonstrated significant price appreciation, with a 52-week high of $41.84 and a low of $12.98, indicating substantial volatility.
The companys financials indicate a negative Return on Equity (RoE) of -0.04, suggesting that it is currently unprofitable. The absence of a forward Price-to-Earnings (P/E) ratio further implies that the company is not expected to generate earnings in the near future. This could be due to various factors, including high operational costs, research and development expenses, or investment in growth initiatives.
To evaluate IPXs potential, key economic drivers such as commodity prices, production costs, and demand for its products should be considered. The companys diversified metals and mining portfolio may provide a hedge against market fluctuations, but it also introduces complexity and potential operational risks. Key Performance Indicators (KPIs) to monitor include revenue growth, production volumes, and cash flow management.
From a trading perspective, IPXs beta of 0.388 suggests that the stock is relatively less volatile than the overall market. However, the Average True Range (ATR) of 1.59, representing a 3.79% daily price movement, indicates that the stock still experiences significant daily fluctuations. The stocks short-term and long-term moving averages (SMA20, SMA50, and SMA200) suggest a bullish trend, with the short-term averages above the long-term averages.
To make an informed investment decision, it is essential to analyze IPXs financial statements, managements guidance, and industry trends. A thorough examination of the companys quarterly tax provision and other financial metrics can provide insights into its profitability, cash flow, and overall financial health.
IPX Stock Overview
| Market Cap in USD | 1,612m |
| Sub-Industry | Diversified Metals & Mining |
| IPO / Inception | 2022-06-21 |
IPX Stock Ratings
| Growth Rating | 87.4% |
| Fundamental | 35.0% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 52.8% |
| Analyst Rating | 5.0 of 5 |
IPX Dividends
Currently no dividends paidIPX Growth Ratios
| Growth Correlation 3m | 66.2% |
| Growth Correlation 12m | 60.9% |
| Growth Correlation 5y | 95.6% |
| CAGR 5y | 101.17% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.54 |
| CAGR/Mean DD 3y (Pain Ratio) | 5.23 |
| Sharpe Ratio 12m | -0.06 |
| Alpha | 76.82 |
| Beta | 0.352 |
| Volatility | 67.10% |
| Current Volume | 199.9k |
| Average Volume 20d | 159.2k |
| Stop Loss | 38.7 (-7.1%) |
| Signal | -1.72 |
Piotroski VR‑10 (Strict, 0-10) 0.0
| error: Net Income check cannot be calculated (needs Net Income TTM and Revenue TTM) |
| FCFTA -0.51 (>2.0%) and ΔFCFTA -29.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| error: NWC/Revenue cannot be calculated (needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.30 (>3.0%) and CFO -31.8m > Net Income -35.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 6.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (29.5m) change vs 12m ago 30.47% (target <= -2.0% for YES) |
| error: Gross Margin (current vs previous) cannot be calculated (needs Total Revenue and Cost Of Revenue) |
| Asset Turnover 0.0% (prev 0.0%; Δ 0.0pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -107.1 (EBITDA TTM -37.8m / Interest Expense TTM 366.8k) >= 6 (WARN >= 3) |
Altman Z'' 4.18
| (A) 0.48 = (Total Current Assets 58.9m - Total Current Liabilities 8.43m) / Total Assets 105.0m |
| (B) -1.04 = Retained Earnings (Balance) -109.2m / Total Assets 105.0m |
| warn (B) unusual magnitude: -1.04 — check mapping/units |
| (C) -0.49 = EBIT TTM -39.3m / Avg Total Assets 80.2m |
| (D) 7.34 = Book Value of Equity 92.4m / Total Liabilities 12.6m |
| Total Rating: 4.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.01
| 1. Piotroski 0.0pt = -5.0 |
| 2. FCF Yield -3.41% = -1.71 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.04 = 2.50 |
| 5. Debt/Ebitda 1.35 = 1.23 |
| 6. ROIC - WACC (= -36.70)% = -12.50 |
| 7. RoE -35.73% = -2.50 |
| 8. Revenue Trend data missing |
| 9. EPS Trend 59.85% = 2.99 |
What is the price of IPX shares?
Over the past week, the price has changed by -10.48%, over one month by -24.48%, over three months by +4.07% and over the past year by +85.49%.
Is IperionX American a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IPX is around 51.44 USD . This means that IPX is currently undervalued and has a potential upside of +23.42% (Margin of Safety).
Is IPX a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.7 | 33.6% |
| Analysts Target Price | 55.7 | 33.6% |
| ValueRay Target Price | 56.7 | 36.1% |
IPX Fundamental Data Overview October 25, 2025
P/E Forward = 1250.0
P/B = 19.0926
Beta = 0.352
Revenue TTM = 0.0 USD
EBIT TTM = -39.3m USD
EBITDA TTM = -37.8m USD
Long Term Debt = 3.46m USD (estimated: total debt 3.93m - short term 472.0k)
Short Term Debt = 472.0k USD (from shortTermDebt, last quarter)
Debt = 3.93m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -50.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.56b USD (1.61b + Debt 3.93m - CCE 54.8m)
Interest Coverage Ratio = -107.1 (Ebit TTM -39.3m / Interest Expense TTM 366.8k)
FCF Yield = -3.41% (FCF TTM -53.3m / Enterprise Value 1.56b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 2.63m) / Revenue TTM)
Tobins Q-Ratio = 14.87 (Enterprise Value 1.56b / Total Assets 105.0m)
Interest Expense / Debt = 0.03% (Interest Expense 1323 / Debt 3.93m)
Taxrate = 21.0% (US default 21%)
NOPAT = -31.0m (EBIT -39.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.99 (Total Current Assets 58.9m / Total Current Liabilities 8.43m)
Debt / Equity = 0.04 (Debt 3.93m / totalStockholderEquity, last quarter 92.4m)
Debt / EBITDA = 1.35 (negative EBITDA) (Net Debt -50.9m / EBITDA -37.8m)
Debt / FCF = 0.95 (negative FCF - burning cash) (Net Debt -50.9m / FCF TTM -53.3m)
Total Stockholder Equity = 99.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -33.67% (Net Income -35.4m / Total Assets 105.0m)
RoE = -35.73% (Net Income TTM -35.4m / Total Stockholder Equity 99.0m)
RoCE = -38.35% (EBIT -39.3m / Capital Employed (Equity 99.0m + L.T.Debt 3.46m))
RoIC = -29.40% (negative operating profit) (NOPAT -31.0m / Invested Capital 105.6m)
WACC = 7.29% (E(1.61b)/V(1.62b) * Re(7.31%) + D(3.93m)/V(1.62b) * Rd(0.03%) * (1-Tc(0.21)))
Discount Rate = 7.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 18.46%
Fair Price DCF = unknown (Cash Flow -53.3m)
EPS Correlation: 59.85 | EPS CAGR: 620.3% | SUE: 0.0 | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0
Additional Sources for IPX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle